COVIDIEN EVERFLEX SELF-EXPANDING PERIPHERAL STENT WITH ENTRUST DELIVERY SYSTEM LONG; STENT, SUPERFICIAL FEMORAL ARTERY
|
Back to Search Results |
|
Catalog Number EVR35-05-150-120 |
Device Problems
Activation, Positioning or Separation Problem (2906); Material Deformation (2976)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 08/30/2023 |
Event Type
malfunction
|
Event Description
|
A physician was implanting an everflex entrust for treatment of a 200mm plaque lesion with chronic total occlusion in the mid right superficial femoral artery.The artery was 5mm in diameter with severe tortuosity and moderate calcification.A 6fr non medtronic sheath and a 0.018" non medtronic guidewire was used.Embolic protection was not used.The device was prepped as per the ifu with no issues identified.No damage to the deployment mechanisms or device handle prior to the deployment issue.The thumbscrew was checked for securement.The lock-pin was removed prior to the case.The lesion was pre-dilated with a 5mm pre-dilation device.The device did not pass through a previously deployed stent.There was no resistance during advancement.It was reported the stent would no deploy 1/4 of the way after initial deployed, it seemed to be jammed in the artery.The physician cut down on the outer sheath, dismembered the handle and then started to put back the outer sheath while deploying the stent.The distal end of the stent that had deployed normally was elongated but the rest of the stent was deployed at nominal.No patient injury was reported.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
Additional information: the stent was post dilated.Product analysis: the device was returned with the red safety tab out of the device, the stent was deployed and there was a guidewire stuck in the device.Kinks were observed on the silver outer sheath at approx.22.2, 23.4, and 24.4cm.The guidewire was measured and measured as 0.018¿.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|